The Trends and Hotspots in Premature Ovarian Insufficiency Therapy from 2000 to 2022

Int J Environ Res Public Health. 2022 Sep 17;19(18):11728. doi: 10.3390/ijerph191811728.

Abstract

This study aims to map the knowledge structure and themes trends of primary ovarian insufficiency (POI) therapy to help researchers rapidly master the hotspots and prospects of POI therapy from the increasing number of publications. The literature search and bibliometric analyses were performed by using Web of Science Core Collection and VOSviewer. Annual publications from 2000 to 2022 continued to increase with some fluctuations. The most productive country, organization, and journal were the USA, Shanghai Jiao Tong University, and Human Reproduction, respectively. Harvard University was the organization with the highest citation. Fertility and Sterility and Nelson, L.M. were the most influential journal and author, respectively. Seven clusters separated by keywords association showed the extensive scope of POI therapy. The hotspots of POI therapy were hormone replacement therapy and fertility preservation, and the innovative treatment strategies including in vitro activation and mesenchymal stem cells had development potential. In addition, our result showed that the high-cited articles were published in journals with high impact factors. The paper provides a comprehensive overview of the development and hotspots of POI therapy, allowing researchers to recognize the current status and future directions of POI therapy.

Keywords: bibliometric analysis; primary ovarian insufficiency; science mapping; therapy.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bibliometrics
  • Biomedical Research*
  • China
  • Efficiency
  • Humans
  • Publications

Grants and funding

This research was funded by the State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, China (Grant No. SKL2020Z0306). In addition, this research was partly funded by the High-level innovation and entrepreneurship team of Liaoning Province, China (XLYC2008029) and Liaoning Revitalization Talents Program, China (No. XLYC1908031).